APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dolutegravir Sodium

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dolutegravir Sodium Industry Growth and Trends Forecast to 2032

23 December 202594 pages

Choose your research edition.

Industry ResearchDolutegravir Sodium Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Dolutegravir Sodium Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Dolutegravir Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dolutegravir Sodium Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Dolutegravir Sodium Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Dolutegravir Sodium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dolutegravir Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dolutegravir Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dolutegravir Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dolutegravir Sodium include Mylan, ViiV Healthcare UK, Ranbaxy Pharmaceuticals, LAURUS Labs, Emcure Pharmaceuticals, Cipla, Aurobindo Pharma and Adcock Ingram Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dolutegravir Sodium market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dolutegravir Sodium market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dolutegravir Sodium market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dolutegravir Sodium.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dolutegravir Sodium market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dolutegravir Sodium Market by Company

Mylan

ViiV Healthcare UK

Ranbaxy Pharmaceuticals

LAURUS Labs

Emcure Pharmaceuticals

Cipla

Aurobindo Pharma

Adcock Ingram Limited

Dolutegravir Sodium Segment by Type

Bottled Packaging

Film Coated Packaging

Dolutegravir Sodium Segment by Application

AIDS Adult Patients

AIDS Children over 12 Years Old

Dolutegravir Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dolutegravir Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dolutegravir Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dolutegravir Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dolutegravir Sodium manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dolutegravir Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Bottled Packaging Table 2. Major Company of Film Coated Packaging Table 3. Global Dolutegravir Sodium Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Dolutegravir Sodium Sales by Type (2021-2026) & (k pcs) Table 5. Global Dolutegravir Sodium Sales Market Share in Volume by Type (2021-2026) Table 6. Global Dolutegravir Sodium Sales by Type (2021-2026) & (US$ Million) Table 7. Global Dolutegravir Sodium Sales Market Share in Value by Type (2021-2026) Table 8. Global Dolutegravir Sodium Price by Type (2021-2026) & (US$/pcs) Table 9. Global Dolutegravir Sodium Sales by Type (2027-2032) & (k pcs) Table 10. Global Dolutegravir Sodium Sales Market Share in Volume by Type (2027-2032) Table 11. Global Dolutegravir Sodium Sales by Type (2027-2032) & (US$ Million) Table 12. Global Dolutegravir Sodium Sales Market Share in Value by Type (2027-2032) Table 13. Global Dolutegravir Sodium Price by Type (2027-2032) & (US$/pcs) Table 14. North America Dolutegravir Sodium Sales by Type (2021-2026) & (k pcs) Table 15. North America Dolutegravir Sodium Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Dolutegravir Sodium Sales by Type (2021-2026) & (k pcs) Table 17. Europe Dolutegravir Sodium Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Dolutegravir Sodium Sales by Type (2021-2026) & (k pcs) Table 19. Asia-Pacific Dolutegravir Sodium Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Dolutegravir Sodium Sales by Type (2021-2026) & (k pcs) Table 21. Latin America Dolutegravir Sodium Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Dolutegravir Sodium Sales by Type (2021-2026) & (k pcs) Table 23. Middle East and Africa Dolutegravir Sodium Sales by Type (2021-2026) & (US$ Million) Table 24. Dolutegravir Sodium Industry Trends Table 25. Dolutegravir Sodium Industry Drivers Table 26. Dolutegravir Sodium Industry Opportunities and Challenges Table 27. Dolutegravir Sodium Industry Restraints Table 28. Global Dolutegravir Sodium Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Dolutegravir Sodium Revenue Market Share by Company (2021-2026) Table 30. Global Dolutegravir Sodium Sales by Company (2021-2026) & (k pcs) Table 31. Global Dolutegravir Sodium Sales Share by Company (2021-2026) Table 32. Global Dolutegravir Sodium Market Price by Company (2021-2026) & (US$/pcs) Table 33. Global Dolutegravir Sodium Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Dolutegravir Sodium Major Company Production Sites and Headquarters Table 35. Global Dolutegravir Sodium Company, Product Type & Application Table 36. Global Dolutegravir Sodium Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Dolutegravir Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Dolutegravir Sodium Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Dolutegravir Sodium Sales by Region (2021-2026) & (k pcs) Table 41. Global Dolutegravir Sodium Sales Market Share in Volume by Region (2021-2026) Table 42. Global Dolutegravir Sodium Sales by Region (2021-2026) & (US$ Million) Table 43. Global Dolutegravir Sodium Sales Market Share in Value by Region (2021-2026) Table 44. Global Dolutegravir Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 45. Global Dolutegravir Sodium Sales by Region (2027-2032) & (k pcs) Table 46. Global Dolutegravir Sodium Sales Market Share in Volume by Region (2027-2032) Table 47. Global Dolutegravir Sodium Sales by Region (2027-2032) & (US$ Million) Table 48. Global Dolutegravir Sodium Sales Market Share in Value by Region (2027-2032) Table 49. Global Dolutegravir Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2027-2032) Table 50. Global Dolutegravir Sodium Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Dolutegravir Sodium Sales by Application (2021-2026) & (k pcs) Table 52. Global Dolutegravir Sodium Sales Market Share in Volume by Application (2021-2026) Table 53. Global Dolutegravir Sodium Sales by Application (2021-2026) & (US$ Million) Table 54. Global Dolutegravir Sodium Sales Market Share in Value by Application (2021-2026) Table 55. Global Dolutegravir Sodium Price by Application (2021-2026) & (US$/pcs) Table 56. Global Dolutegravir Sodium Sales by Application (2027-2032) & (k pcs) Table 57. Global Dolutegravir Sodium Sales Market Share in Volume by Application (2027-2032) Table 58. Global Dolutegravir Sodium Sales by Application (2027-2032) & (US$ Million) Table 59. Global Dolutegravir Sodium Sales Market Share in Value by Application (2027-2032) Table 60. Global Dolutegravir Sodium Price by Application (2027-2032) & (US$/pcs) Table 61. North America Dolutegravir Sodium Sales by Application (2021-2026) & (k pcs) Table 62. North America Dolutegravir Sodium Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Dolutegravir Sodium Sales by Application (2021-2026) & (k pcs) Table 64. Europe Dolutegravir Sodium Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Dolutegravir Sodium Sales by Application (2021-2026) & (k pcs) Table 66. Asia-Pacific Dolutegravir Sodium Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Dolutegravir Sodium Sales by Application (2021-2026) & (k pcs) Table 68. Latin America Dolutegravir Sodium Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Dolutegravir Sodium Sales by Application (2021-2026) & (k pcs) Table 70. Middle East and Africa Dolutegravir Sodium Sales by Application (2021-2026) & (US$ Million) Table 71. Mylan Company Information Table 72. Mylan Business Overview Table 73. Mylan Dolutegravir Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 74. Mylan Dolutegravir Sodium Product Portfolio Table 75. Mylan Recent Development Table 76. ViiV Healthcare UK Company Information Table 77. ViiV Healthcare UK Business Overview Table 78. ViiV Healthcare UK Dolutegravir Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 79. ViiV Healthcare UK Dolutegravir Sodium Product Portfolio Table 80. ViiV Healthcare UK Recent Development Table 81. Ranbaxy Pharmaceuticals Company Information Table 82. Ranbaxy Pharmaceuticals Business Overview Table 83. Ranbaxy Pharmaceuticals Dolutegravir Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 84. Ranbaxy Pharmaceuticals Dolutegravir Sodium Product Portfolio Table 85. Ranbaxy Pharmaceuticals Recent Development Table 86. LAURUS Labs Company Information Table 87. LAURUS Labs Business Overview Table 88. LAURUS Labs Dolutegravir Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 89. LAURUS Labs Dolutegravir Sodium Product Portfolio Table 90. LAURUS Labs Recent Development Table 91. Emcure Pharmaceuticals Company Information Table 92. Emcure Pharmaceuticals Business Overview Table 93. Emcure Pharmaceuticals Dolutegravir Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 94. Emcure Pharmaceuticals Dolutegravir Sodium Product Portfolio Table 95. Emcure Pharmaceuticals Recent Development Table 96. Cipla Company Information Table 97. Cipla Business Overview Table 98. Cipla Dolutegravir Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 99. Cipla Dolutegravir Sodium Product Portfolio Table 100. Cipla Recent Development Table 101. Aurobindo Pharma Company Information Table 102. Aurobindo Pharma Business Overview Table 103. Aurobindo Pharma Dolutegravir Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 104. Aurobindo Pharma Dolutegravir Sodium Product Portfolio Table 105. Aurobindo Pharma Recent Development Table 106. Adcock Ingram Limited Company Information Table 107. Adcock Ingram Limited Business Overview Table 108. Adcock Ingram Limited Dolutegravir Sodium Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 109. Adcock Ingram Limited Dolutegravir Sodium Product Portfolio Table 110. Adcock Ingram Limited Recent Development Table 111. North America Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 112. North America Dolutegravir Sodium Sales by Country (2021-2026) & (k pcs) Table 113. North America Dolutegravir Sodium Sales Market Share by Country (2021-2026) Table 114. North America Dolutegravir Sodium Sales Forecast by Country (2027-2032) & (k pcs) Table 115. North America Dolutegravir Sodium Sales Market Share Forecast by Country (2027-2032) Table 116. North America Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Dolutegravir Sodium Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Dolutegravir Sodium Market Share by Country (2021-2026) Table 119. North America Dolutegravir Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Dolutegravir Sodium Market Share Forecast by Country (2027-2032) Table 121. Europe Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 122. Europe Dolutegravir Sodium Sales by Country (2021-2026) & (k pcs) Table 123. Europe Dolutegravir Sodium Sales Market Share by Country (2021-2026) Table 124. Europe Dolutegravir Sodium Sales Forecast by Country (2027-2032) & (k pcs) Table 125. Europe Dolutegravir Sodium Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Dolutegravir Sodium Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Dolutegravir Sodium Market Share by Country (2021-2026) Table 129. Europe Dolutegravir Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Dolutegravir Sodium Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Dolutegravir Sodium Sales by Country (2021-2026) & (k pcs) Table 133. Asia-Pacific Dolutegravir Sodium Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Dolutegravir Sodium Sales Forecast by Country (2027-2032) & (k pcs) Table 135. Asia-Pacific Dolutegravir Sodium Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Dolutegravir Sodium Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Dolutegravir Sodium Market Share by Country (2021-2026) Table 139. Asia-Pacific Dolutegravir Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Dolutegravir Sodium Market Share Forecast by Country (2027-2032) Table 141. Latin America Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 142. Latin America Dolutegravir Sodium Sales by Country (2021-2026) & (k pcs) Table 143. Latin America Dolutegravir Sodium Sales Market Share by Country (2021-2026) Table 144. Latin America Dolutegravir Sodium Sales Forecast by Country (2027-2032) & (k pcs) Table 145. Latin America Dolutegravir Sodium Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Dolutegravir Sodium Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Dolutegravir Sodium Market Share by Country (2021-2026) Table 149. Latin America Dolutegravir Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Dolutegravir Sodium Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Dolutegravir Sodium Sales by Country (2021-2026) & (k pcs) Table 153. Middle East and Africa Dolutegravir Sodium Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Dolutegravir Sodium Sales Forecast by Country (2027-2032) & (k pcs) Table 155. Middle East and Africa Dolutegravir Sodium Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Dolutegravir Sodium Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Dolutegravir Sodium Market Share by Country (2021-2026) Table 159. Middle East and Africa Dolutegravir Sodium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Dolutegravir Sodium Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Dolutegravir Sodium Distributors List Table 164. Dolutegravir Sodium Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Dolutegravir Sodium Image Figure 2. Global Dolutegravir Sodium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dolutegravir Sodium Market Size (2021-2032) & (US$ Million) Figure 4. Global Dolutegravir Sodium Sales (2021-2032) & (k pcs) Figure 5. Bottled Packaging Image Figure 6. Global Bottled Packaging Sales YoY Growth (2021-2032) & (k pcs) Figure 7. Film Coated Packaging Image Figure 8. Global Film Coated Packaging Sales YoY Growth (2021-2032) & (k pcs) Figure 9. Global Dolutegravir Sodium Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Dolutegravir Sodium Market Share by Type 2025 VS 2032 Figure 11. North America Dolutegravir Sodium Sales Market Share in Volume by Type in 2025 Figure 12. North America Dolutegravir Sodium Sales Market Share in Value by Type in 2025 Figure 13. Europe Dolutegravir Sodium Sales Market Share in Volume by Type in 2025 Figure 14. Europe Dolutegravir Sodium Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Dolutegravir Sodium Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Dolutegravir Sodium Sales Market Share in Value by Type in 2025 Figure 17. Latin America Dolutegravir Sodium Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Dolutegravir Sodium Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Dolutegravir Sodium Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Dolutegravir Sodium Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Dolutegravir Sodium Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. AIDS Adult Patients Image Figure 24. Global AIDS Adult Patients Sales YoY Growth (2021-2032) & (k pcs) Figure 25. AIDS Children over 12 Years Old Image Figure 26. Global AIDS Children over 12 Years Old Sales YoY Growth (2021-2032) & (k pcs) Figure 27. Global Dolutegravir Sodium Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Dolutegravir Sodium Market Share by Application 2025 VS 2032 Figure 29. North America Dolutegravir Sodium Sales Market Share in Volume by Application in 2025 Figure 30. North America Dolutegravir Sodium Sales Market Share in Value by Application in 2025 Figure 31. Europe Dolutegravir Sodium Sales Market Share in Volume by Application in 2025 Figure 32. Europe Dolutegravir Sodium Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Dolutegravir Sodium Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Dolutegravir Sodium Sales Market Share in Value by Application in 2025 Figure 35. Latin America Dolutegravir Sodium Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Dolutegravir Sodium Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Dolutegravir Sodium Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Dolutegravir Sodium Sales Market Share in Value by Application in 2025 Figure 39. North America Dolutegravir Sodium Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 40. North America Dolutegravir Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Dolutegravir Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Dolutegravir Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Dolutegravir Sodium Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 44. Europe Dolutegravir Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Dolutegravir Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Dolutegravir Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Dolutegravir Sodium Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 48. Asia-Pacific Dolutegravir Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Dolutegravir Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Dolutegravir Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Dolutegravir Sodium Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 52. Latin America Dolutegravir Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Dolutegravir Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Dolutegravir Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Dolutegravir Sodium Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 56. Middle East and Africa Dolutegravir Sodium Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Dolutegravir Sodium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Dolutegravir Sodium Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Dolutegravir Sodium Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Dolutegravir Sodium Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Bottled Packaging
  • Film Coated Packaging
Applications
  • AIDS Adult Patients
  • AIDS Children over 12 Years Old
Companies covered
  • Mylan
  • ViiV Healthcare UK
  • Ranbaxy Pharmaceuticals
  • LAURUS Labs
  • Emcure Pharmaceuticals
  • Cipla
  • Aurobindo Pharma
  • Adcock Ingram Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dolutegravir Sodium Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dolutegravir Sodium Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dolutegravir Sodium Market by Type
  6. 1.3.1 Bottled Packaging
  7. 1.3.2 Film Coated Packaging
  8. 1.4 Global Dolutegravir Sodium Market Size by Type
  9. 1.4.1 Global Dolutegravir Sodium Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Dolutegravir Sodium Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Dolutegravir Sodium Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Dolutegravir Sodium Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Dolutegravir Sodium Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Dolutegravir Sodium Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Dolutegravir Sodium Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Dolutegravir Sodium Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dolutegravir Sodium Industry Trends
  2. 2.2 Dolutegravir Sodium Industry Drivers
  3. 2.3 Dolutegravir Sodium Industry Opportunities and Challenges
  4. 2.4 Dolutegravir Sodium Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dolutegravir Sodium Revenue (2021-2026)
  2. 3.2 Global Top Players by Dolutegravir Sodium Sales (2021-2026)
  3. 3.3 Global Top Players by Dolutegravir Sodium Price (2021-2026)
  4. 3.4 Global Dolutegravir Sodium Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dolutegravir Sodium Major Company Production Sites & Headquarters
  6. 3.6 Global Dolutegravir Sodium Company, Product Type & Application
  7. 3.7 Global Dolutegravir Sodium Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dolutegravir Sodium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dolutegravir Sodium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dolutegravir Sodium Tier 1, Tier 2, and Tier 3
4 Dolutegravir Sodium Regional Status and Outlook
  1. 4.1 Global Dolutegravir Sodium Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dolutegravir Sodium Historic Market Size by Region
  3. 4.2.1 Global Dolutegravir Sodium Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dolutegravir Sodium Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dolutegravir Sodium Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dolutegravir Sodium Forecasted Market Size by Region
  7. 4.3.1 Global Dolutegravir Sodium Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dolutegravir Sodium Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dolutegravir Sodium Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dolutegravir Sodium by Application
  1. 5.1 Dolutegravir Sodium Market by Application
  2. 5.1.1 AIDS Adult Patients
  3. 5.1.2 AIDS Children over 12 Years Old
  4. 5.2 Global Dolutegravir Sodium Market Size by Application
  5. 5.2.1 Global Dolutegravir Sodium Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Dolutegravir Sodium Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Dolutegravir Sodium Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Dolutegravir Sodium Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Dolutegravir Sodium Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Dolutegravir Sodium Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Dolutegravir Sodium Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Dolutegravir Sodium Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Mylan
  2. 6.1.1 Mylan Company Information
  3. 6.1.2 Mylan Business Overview
  4. 6.1.3 Mylan Dolutegravir Sodium Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Mylan Dolutegravir Sodium Product Portfolio
  6. 6.1.5 Mylan Recent Developments
  7. 6.2 ViiV Healthcare UK
  8. 6.2.1 ViiV Healthcare UK Company Information
  9. 6.2.2 ViiV Healthcare UK Business Overview
  10. 6.2.3 ViiV Healthcare UK Dolutegravir Sodium Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ViiV Healthcare UK Dolutegravir Sodium Product Portfolio
  12. 6.2.5 ViiV Healthcare UK Recent Developments
  13. 6.3 Ranbaxy Pharmaceuticals
  14. 6.3.1 Ranbaxy Pharmaceuticals Company Information
  15. 6.3.2 Ranbaxy Pharmaceuticals Business Overview
  16. 6.3.3 Ranbaxy Pharmaceuticals Dolutegravir Sodium Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ranbaxy Pharmaceuticals Dolutegravir Sodium Product Portfolio
  18. 6.3.5 Ranbaxy Pharmaceuticals Recent Developments
  19. 6.4 LAURUS Labs
  20. 6.4.1 LAURUS Labs Company Information
  21. 6.4.2 LAURUS Labs Business Overview
  22. 6.4.3 LAURUS Labs Dolutegravir Sodium Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 LAURUS Labs Dolutegravir Sodium Product Portfolio
  24. 6.4.5 LAURUS Labs Recent Developments
  25. 6.5 Emcure Pharmaceuticals
  26. 6.5.1 Emcure Pharmaceuticals Company Information
  27. 6.5.2 Emcure Pharmaceuticals Business Overview
  28. 6.5.3 Emcure Pharmaceuticals Dolutegravir Sodium Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Emcure Pharmaceuticals Dolutegravir Sodium Product Portfolio
  30. 6.5.5 Emcure Pharmaceuticals Recent Developments
  31. 6.6 Cipla
  32. 6.6.1 Cipla Company Information
  33. 6.6.2 Cipla Business Overview
  34. 6.6.3 Cipla Dolutegravir Sodium Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cipla Dolutegravir Sodium Product Portfolio
  36. 6.6.5 Cipla Recent Developments
  37. 6.7 Aurobindo Pharma
  38. 6.7.1 Aurobindo Pharma Company Information
  39. 6.7.2 Aurobindo Pharma Business Overview
  40. 6.7.3 Aurobindo Pharma Dolutegravir Sodium Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Aurobindo Pharma Dolutegravir Sodium Product Portfolio
  42. 6.7.5 Aurobindo Pharma Recent Developments
  43. 6.8 Adcock Ingram Limited
  44. 6.8.1 Adcock Ingram Limited Company Information
  45. 6.8.2 Adcock Ingram Limited Business Overview
  46. 6.8.3 Adcock Ingram Limited Dolutegravir Sodium Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Adcock Ingram Limited Dolutegravir Sodium Product Portfolio
  48. 6.8.5 Adcock Ingram Limited Recent Developments
7 North America by Country
  1. 7.1 North America Dolutegravir Sodium Sales by Country
  2. 7.1.1 North America Dolutegravir Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dolutegravir Sodium Sales by Country (2021-2026)
  4. 7.1.3 North America Dolutegravir Sodium Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dolutegravir Sodium Market Size by Country
  6. 7.2.1 North America Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dolutegravir Sodium Market Size by Country (2021-2026)
  8. 7.2.3 North America Dolutegravir Sodium Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dolutegravir Sodium Sales by Country
  2. 8.1.1 Europe Dolutegravir Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dolutegravir Sodium Sales by Country (2021-2026)
  4. 8.1.3 Europe Dolutegravir Sodium Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dolutegravir Sodium Market Size by Country
  6. 8.2.1 Europe Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dolutegravir Sodium Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dolutegravir Sodium Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dolutegravir Sodium Sales by Country
  2. 9.1.1 Asia-Pacific Dolutegravir Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dolutegravir Sodium Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dolutegravir Sodium Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dolutegravir Sodium Market Size by Country
  6. 9.2.1 Asia-Pacific Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dolutegravir Sodium Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dolutegravir Sodium Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dolutegravir Sodium Sales by Country
  2. 10.1.1 South America Dolutegravir Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dolutegravir Sodium Sales by Country (2021-2026)
  4. 10.1.3 South America Dolutegravir Sodium Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dolutegravir Sodium Market Size by Country
  6. 10.2.1 South America Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dolutegravir Sodium Market Size by Country (2021-2026)
  8. 10.2.3 South America Dolutegravir Sodium Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dolutegravir Sodium Sales by Country
  2. 11.1.1 Middle East and Africa Dolutegravir Sodium Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dolutegravir Sodium Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dolutegravir Sodium Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dolutegravir Sodium Market Size by Country
  6. 11.2.1 Middle East and Africa Dolutegravir Sodium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dolutegravir Sodium Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dolutegravir Sodium Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dolutegravir Sodium Value Chain Analysis
  2. 12.1.1 Dolutegravir Sodium Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dolutegravir Sodium Production Mode & Process
  7. 12.2 Dolutegravir Sodium Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dolutegravir Sodium Distributors
  10. 12.2.3 Dolutegravir Sodium Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst